Literature DB >> 22503115

Beyond α-synuclein transfer: pathology propagation in Parkinson's disease.

Christian Hansen1, Jia-Yi Li.   

Abstract

α-Synuclein (α-syn) is the most abundant protein found in Lewy bodies, a hallmark of Parkinson's disease (PD), and can aggregate to form toxic oligomers and fibrillar structures. Recent studies have shown that α-syn can be transmitted between neurons and can seed the formation of toxic aggregates in recipient neurons in a prion-like manner. In addition, it is known that Lewy body pathology may spread gradually and systematically from the peripheral or enteric nervous system or olfactory bulb to specific brain regions during progression of idiopathic PD. It is therefore conceivable that α-syn species could act as seeds that drive PD progression. Here, we review recent advances from studies of α-syn cell-to-cell transfer, the current understanding of α-syn toxicity, and how these relate to progression of PD pathology.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22503115     DOI: 10.1016/j.molmed.2012.03.002

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  34 in total

Review 1.  Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.

Authors:  Nicole Exner; Anne Kathrin Lutz; Christian Haass; Konstanze F Winklhofer
Journal:  EMBO J       Date:  2012-06-26       Impact factor: 11.598

Review 2.  Building a second brain in the bowel.

Authors:  Marina Avetisyan; Ellen Merrick Schill; Robert O Heuckeroth
Journal:  J Clin Invest       Date:  2015-02-09       Impact factor: 14.808

Review 3.  Idiopathic REM sleep behaviour disorder in the development of Parkinson's disease.

Authors:  Bradley F Boeve
Journal:  Lancet Neurol       Date:  2013-04-09       Impact factor: 44.182

Review 4.  Potential of Cellular and Animal Models Based on a Prion-Like Propagation of α-Synuclein for Assessing Antiparkinson Agents.

Authors:  Hiroyasu Sato; Takeo Kato; Shigeki Arawaka
Journal:  Mol Neurobiol       Date:  2014-08-21       Impact factor: 5.590

Review 5.  Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases.

Authors:  Heiko Braak; Kelly Del Tredici
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-11-01       Impact factor: 10.005

6.  Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.

Authors:  Bradley M Coleman; Christopher F Harrison; Belinda Guo; Colin L Masters; Kevin J Barnham; Victoria A Lawson; Andrew F Hill
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

7.  Age-Dependent Alpha-Synuclein Accumulation and Phosphorylation in the Enteric Nervous System in a Transgenic Mouse Model of Parkinson's Disease.

Authors:  Chong-Bin Zhong; Qian-Qian Chen; Caroline Haikal; Wen Li; Alexander Svanbergsson; Meike Diepenbroek; Jia-Yi Li
Journal:  Neurosci Bull       Date:  2017-09-18       Impact factor: 5.203

Review 8.  The role of Rab GTPases in the pathobiology of Parkinson' disease.

Authors:  Luis Bonet-Ponce; Mark R Cookson
Journal:  Curr Opin Cell Biol       Date:  2019-05-01       Impact factor: 8.382

9.  Traumatic brain injury may increase risk of young onset dementia.

Authors:  Raquel C Gardner; Kristine Yaffe
Journal:  Ann Neurol       Date:  2014-03-07       Impact factor: 10.422

10.  The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies.

Authors:  Kay Seidel; Josefine Mahlke; Sonny Siswanto; Reijko Krüger; Helmut Heinsen; Georg Auburger; Mohamed Bouzrou; Lea T Grinberg; Helmut Wicht; Horst-Werner Korf; Wilfred den Dunnen; Udo Rüb
Journal:  Brain Pathol       Date:  2014-09-12       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.